Alzamend Neuro, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alzamend Neuro, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q2 2024.
  • Alzamend Neuro, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was -$974K, a 72.4% increase year-over-year.
  • Alzamend Neuro, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was -$7.39M, a 51.9% increase year-over-year.
  • Alzamend Neuro, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.95M, a 33.1% increase from 2022.
  • Alzamend Neuro, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 20.4% decline from 2021.
  • Alzamend Neuro, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.4M, a 145% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$7.39M -$974K +$2.55M +72.4% May 1, 2024 Jul 31, 2024 10-Q 2024-09-11
Q1 2024 -$9.95M -$852K +$2.45M +74.2% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-30
Q4 2023 -$12.4M -$2.66M +$2.76M +50.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-25
Q3 2023 -$15.2M -$2.91M +$204K +6.56% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 -$15.4M -$3.53M -$491K -16.2% May 1, 2023 Jul 31, 2023 10-Q 2024-09-11
Q1 2023 -$14.9M -$3.31M +$564K +14.6% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-30
Q4 2022 -$15.4M -$5.43M -$2.85M -111% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-25
Q3 2022 -$12.6M -$3.11M +$490K +13.6% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 -$13.1M -$3.04M -$717K -30.9% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q1 2022 -$12.4M -$3.87M -$2.61M -208% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-27
Q4 2021 -$9.75M -$2.57M -$1.45M -130% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-15
Q3 2021 -$8.3M -$3.6M -$2.25M -166% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 -$6.05M -$2.32M -$1M -76.2% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 -$5.05M -$1.26M Feb 1, 2021 Apr 30, 2021 10-K 2022-07-19
Q4 2020 -$1.12M Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$1.35M Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 -$1.32M May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.